Micro-RNAs and breast cancer

Molecular Oncology

Volumn 4, Issue 3, 2010, Pages 230-241

  Le Quesne, John ^a   Caldas, Carlos ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Breast cancer, oncogenes; Micro RNA; Tumor suppressors

Indexed keywords

ESTROGEN RECEPTOR; MESSENGER RNA; MICRORNA; MICRORNA 10; MICRORNA 125; MICRORNA 17-92; MICRORNA 205; MICRORNA 21; MICRORNA 34; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ANGIOGENESIS; BREAST CANCER; CANCER SUSCEPTIBILITY; CELL DIFFERENTIATION; CELL TYPE; DOWN REGULATION; GENE EXPRESSION; GENETIC CODE; GENETIC TRANSCRIPTION; HUMAN; MOLECULAR MECHANICS; NONHUMAN; ONCOGENE; PHENOTYPE; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR SUPPRESSOR GENE; ANIMAL; BREAST TUMOR; CELL TRANSFORMATION; FEMALE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; METABOLISM; PATHOLOGY;

ANIMALS; BREAST NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICRORNAS; RECEPTORS, ESTROGEN;

EID: 77953869515     PISSN: 15747891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molonc.2010.04.009     Document Type: Review

References (138)

1. Adams B.D., Furneaux H., and White B.A. The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-alpha (eralpha) and represses eralpha messenger RNA and protein expression in breast cancer cell lines. Mol. Endocrinol. 21 (2007) 1132-1147
2. Avril-Sassen S., Goldstein L.D., Stingl J., Blenkiron C., Le Quesne J., Spiteri I., Karagavriilidou K., Watson C.J., Tavare S., Miska E.A., and Caldas C. Characterisation of microRNA expression in post-natal mouse mammary gland development. BMC Genomics 10 (2009) 548
3. Baffa R., Fassan M., Volinia S., O'Hara B., Liu C.G., Palazzo J.P., Gardiman M., Rugge M., Gomella L.G., Croce C.M., and Rosenberg A. MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. J. Pathol. 219 (2009) 214-221
4. Bhat-Nakshatri P., Wang G., Collins N.R., Thomson M.J., Geistlinger T.R., Carroll J.S., Brown M., Hammond S., Srour E.F., Liu Y., and Nakshatri H. Estradiol-regulated microRNAs control estradiol response in breast cancer cells. Nucleic Acids Res. 37 (2009) 4850-4861
5. Blenkiron C., Goldstein L.D., Thorne N.P., Spiteri I., Chin S.F., Dunning M.J., Barbosa-Morais N.L., Teschendorff A.E., Green A.R., Ellis I.O., Tavaré S., Caldas C., and Miska E.A. MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol. 8 (2007) R214
6. Bommer G.T., Gerin I., Feng Y., Kaczorowski A.J., Kuick R., Love R.E., Zhai Y., Giordano T.J., Qin Z.S., Moore B.B., MacDougald O.A., Cho K.R., and Fearon E.R. P53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr. Biol. 17 (2007) 1298-1307
7. Bourguignon L.Y., Spevak C.C., Wong G., Xia W., and Gilad E. Hyaluronan-cd44 interaction with PKC-epsilon promotes oncogenic signaling by the stem cell marker, Nanog and the production of microRNA-21, leading to down-regulation of the tumor suppressor protein, PDCD4, anti-apoptosis and chemotherapy resistance in breast tumor cells. J. Biol. Chem. 284 (2009) 26533-26546
8. Boyerinas B., Park S.M., Shomron N., Hedegaard M.M., Vinther J., Andersen J.S., Feig C., Xu J., Burge C.B., and Peter M.E. Identification of let-7-regulated oncofetal genes. Cancer Res. 68 (2008) 2587-2591
9. Burk U., Schubert J., Wellner U., Schmalhofer O., Vincan E., Spaderna S., and Brabletz T. A reciprocal repression between ZEB1 and members of the miR-200 family promotes emt and invasion in cancer cells. EMBO Rep. 9 (2008) 582-589
10. Calin G.A., Sevignani C., Dumitru C.D., Hyslop T., Noch E., Yendamuri S., Shimizu M., Rattan S., Bullrich F., Negrini M., and Croce C.M. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. U S A 101 (2004) 2999-3004
11. Carrio M., Arderiu G., Myers C., and Boudreau N.J. Homeobox D10 induces phenotypic reversion of breast tumor cells in a three-dimensional culture model. Cancer Res. 65 (2005) 7177-7185
12. Castellano L., Giamas G., Jacob J., Coombes R.C., Lucchesi W., Thiruchelvam P., Barton G., Jiao L.R., Wait R., Waxman J., Hannon G.J., and Stebbing J. The estrogen receptor-alpha-induced microRNA signature regulates itself and its transcriptional response. Proc. Natl. Acad. Sci. U S A 106 (2009) 15732-15737
13. Chan J.A., Krichevsky A.M., and Kosik K.S. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 65 (2005) 6029-6033
14. Dangi-Garimella S., Yun J., Eves E.M., Newman M., Erkeland S.J., Hammond S.M., Minn A.J., and Rosner M.R. Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7. EMBO J. 28 (2009) 347-358
15. Davis B.N., Hilyard A.C., Lagna G., and Hata A. SMAD proteins control DROSHA-mediated microRNA maturation. Nature 454 (2008) 56-61
16. Dykxhoorn D.M., Wu Y., Xie H., Yu F., Lal A., Petrocca F., Martinvalet D., Song E., Lim B., and Lieberman J. miR-200 enhances mouse breast cancer cell colonization to form distant metastases. PLoS One 4 (2009) e7181
17. Findlay V.J., Turner D.P., Moussa O., and Watson D.K. MicroRNA-mediated inhibition of prostate-derived Ets factor messenger RNA translation affects prostate-derived Ets factor regulatory networks in human breast cancer. Cancer Res. 68 (2008) 8499-8506
18. Frankel L.B., Christoffersen N.R., Jacobsen A., Lindow M., Krogh A., and Lund A.H. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J. Biol. Chem. 283 (2008) 1026-1033
19. Friedman R.C., Farh K.K., Burge C.B., and Bartel D.P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19 (2009) 92-105
20. Garzon R., Pichiorri F., Palumbo T., Iuliano R., Cimmino A., Aqeilan R., Volinia S., Bhatt D., Alder H., Marcucci G., Calin G.A., Liu C.G., Bloomfield C.D., Andreeff M., and Croce C.M. MicroRNA fingerprints during human megakaryocytopoiesis. Proc. Natl. Acad. Sci. USA 103 (2006) 5078-5083
21. Gaur A., Jewell D.A., Liang Y., Ridzon D., Moore J.H., Chen C., Ambros V.R., and Israel M.A. Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res. 67 (2007) 2456-2468
22. Gebeshuber C.A., Zatloukal K., and Martinez J. miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis. EMBO Rep. 10 (2009) 400-405
23. Gee H.E., Camps C., Buffa F.M., Colella S., Sheldon H., Gleadle J.M., Ragoussis J., and Harris A.L. MicroRNA-10b and breast cancer metastasis. Nature 455 (2008) E8-E9 author reply E9
24. Git A., Spiteri I., Blenkiron C., Dunning M.J., Pole J.C., Chin S.F., Wang Y., Smith J., Livesey F.J., and Caldas C. PMC42, a breast progenitor cancer cell line, has normal-like mRNA and microRNA transcriptomes. Breast Cancer Res. 10 (2008) R54
25. Git A., Dvinghe H., Salmon-Divon M., Osborne M., Kutter C., Hadfield J., Bertone P., and Caldas C. Systematic comparison of microarray profiling, real-time PCR, and next-generation sequencing technologies for measuring differential microRNA expression. RNA 16 (2010) 991-1006
26. Gregory P.A., Bert A.G., Paterson E.L., Barry S.C., Tsykin A., Farshid G., Vadas M.A., Khew-Goodall Y., and Goodall G.J. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol. 10 (2008) 593-601
27. Grelier G., Voirin N., Ay A.S., Cox D.G., Chabaud S., Treilleux I., Leon-Goddard S., Rimokh R., Mikaelian I., Venoux C., Puisieux A., Lasset C., and Moyret-Lalle C. Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype. Br. J. Cancer 101 (2009) 673-683
28. Guo X., Wu Y., and Hartley R.S. MicroRNA-125a represses cell growth by targeting HuR in breast cancer. RNA Biol. 6 (2009)
29. Guttilla I.K., and White B.A. Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells. J. Biol. Chem. 284 (2009) 23204-23216
30. Han L., Witmer P.D., Casey E., Valle D., and Sukumar S. DNA methylation regulates microRNA expression. Cancer Biol. Ther. 6 (2007) 1284-1288
31. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
32. Hasemeier B., Christgen M., Kreipe H., and Lehmann U. Reliable microRNA profiling in routinely processed formalin-fixed paraffin-embedded breast cancer specimens using fluorescence labelled bead technology. BMC Biotechnol. 8 (2008) 90
33. He L., Thomson J.M., Hemann M.T., Hernando-Monge E., Mu D., Goodson S., Powers S., Cordon-Cardo C., Lowe S.W., Hannon G.J., and Hammond S.M. A microRNA polycistron as a potential human oncogene. Nature 435 (2005) 828-833
34. He L., He X., Lim L.P., de Stanchina E., Xuan Z., Liang Y., Xue W., Zender L., Magnus J., Ridzon D., Jackson A.L., Linsley P.S., Chen C., Lowe S.W., Cleary M.A., and Hannon G.J. A microRNA component of the p53 tumour suppressor network. Nature 447 (2007) 1130-1134
35. Heinonen M., Bono P., Narko K., Chang S.H., Lundin J., Joensuu H., Furneaux H., Hla T., Haglund C., and Ristimaki A. Cytoplasmic HuR expression is a prognostic factor in invasive ductal breast carcinoma. Cancer Res. 65 (2005) 2157-2161
36. Hendrickson D.G., Hogan D.J., McCullough H.L., Myers J.W., Herschlag D., Ferrell J.E., and Brown P.O. Concordant regulation of translation and mRNA abundance for hundreds of targets of a human microRNA. PLoS Biol. 7 (2009) e1000238
37. Heo I., Joo C., Cho J., Ha M., Han J., and Kim V.N. Lin28 mediates the terminal uridylation of let-7 precursor microRNA. Mol. Cell 32 (2008) 276-284
38. Hoffman A.E., Zheng T., Yi C., Leaderer D., Weidhaas J., Slack F., Zhang Y., Paranjape T., and Zhu Y. MicroRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis. Cancer Res. 69 (2009) 5970-5977
39. Hossain A., Kuo M.T., and Saunders G.F. miR-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA. Mol. Cell Biol. 26 (2006) 8191-8201
40. Hu Z., Liang J., Wang Z., Tian T., Zhou X., Chen J., Miao R., Wang Y., Wang X., and Shen H. Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in chinese women. Hum. Mutat. 30 (2009) 79-84
41. Huang Q., Gumireddy K., Schrier M., le Sage C., Nagel R., Nair S., Egan D.A., Li A., Huang G., Klein-Szanto A.J., Gimotty P.A., Katsaros D., Coukos G., Zhang L., Pure E., and Agami R. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat. Cell Biol. 10 (2008) 202-210
42. Huang G.L., Zhang X.H., Guo G.L., Huang K.T., Yang K.Y., Shen X., You J., and Hu X.Q. Clinical significance of miR-21 expression in breast cancer: SYBR-green I-based real-time RT-PCR study of invasive ductal carcinoma. Oncol. Rep. 21 (2009) 673-679
43. Hurst D.R., Edmonds M.D., Scott G.K., Benz C.C., Vaidya K.S., and Welch D.R. Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Res. 69 (2009) 1279-1283
44. Hurteau G.J., Carlson J.A., Spivack S.D., and Brock G.J. Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of e-cadherin. Cancer Res. 67 (2007) 7972-7976
45. (2009). http://www.mirbase.org/
46. Ibarra I., Erlich Y., Muthuswamy S.K., Sachidanandam R., and Hannon G.J. A role for microRNAs in maintenance of mouse mammary epithelial progenitor cells. Genes Dev. 21 (2007) 3238-3243
47. Iliopoulos D., Hirsch H.A., and Struhl K. An epigenetic switch involving NF-kappaB, Lin28, Let-7 microRNA, and IL6 links inflammation to cell transformation. Cell 139 (2009) 693-706
48. Iorio M.V., Ferracin M., Liu C.G., Veronese A., Spizzo R., Sabbioni S., Magri E., Pedriali M., Fabbri M., Campiglio M., Menard S., Palazzo J.P., Rosenberg A., Musiani P., Volinia S., Nenci I., Calin G.A., Querzoli P., Negrini M., and Croce C.M. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 65 (2005) 7065-7070
49. Iorio M.V., Casalini P., Piovan C., Di Leva G., Merlo A., Triulzi T., Ménard S., Croce C.M., and Tagliabue E. MicroRNA-205 regulates HER3 in human breast cancer. Cancer Res. 69 (2009) 2195-2200
50. Ivanovska I., Ball A.S., Diaz R.L., Magnus J.F., Kibukawa M., Schelter J.M., Kobayashi S.V., Lim L., Burchard J., Jackson A.L., Linsley P.S., and Cleary M.A. MicroRNAs in the miR-106b family regulate p21/CDKN1a and promote cell cycle progression. Mol. Cell Biol. 28 (2008) 2167-2174
51. Jazdzewski K., Murray E.L., Franssila K., Jarzab B., Schoenberg D.R., and de la Chapelle A. Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc. Natl. Acad. Sci. U S A 105 (2008) 7269-7274
52. Johnson S.M., Grosshans H., Shingara J., Byrom M., Jarvis R., Cheng A., Labourier E., Reinert K.L., Brown D., and Slack F.J. Ras is regulated by the let-7 microRNA family. Cell 120 (2005) 635-647
53. Kato M., Paranjape T., Muller R.U., Nallur S., Gillespie E., Keane K., Esquela-Kerscher A., Weidhaas J.B., and Slack F.J. The miR-34 microRNA is required for the DNA damage response in vivo in C. elegans and in vitro in human breast cancer cells. Oncogene 28 (2009) 2419-2424
54. Khoshnaw S.M., Green A.R., Powe D.G., and Ellis I.O. MicroRNA involvement in the pathogenesis and management of breast cancer. J. Clin. Pathol. 62 (2009) 422-428
55. Komagata S., Nakajima M., Takagi S., Mohri T., Taniya T., and Yokoi T. Human CYP24 catalyzing the inactivation of calcitriol is post-transcriptionally regulated by miR-125b. Mol. Pharmacol. 76 (2009) 702-709
56. Kong Y.W., Cannell I.G., de Moor C.H., Hill K., Garside P.G., Hamilton T.L., Meijer H.A., Dobbyn H.C., Stoneley M., Spriggs K.A., Willis A.E., and Bushell M. The mechanism of micro-RNA-mediated translation repression is determined by the promoter of the target gene. Proc. Natl. Acad. Sci. U S A 105 (2008) 8866-8871
57. Kumar M.S., Lu J., Mercer K.L., Golub T.R., and Jacks T. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat. Genet. 39 (2007) 673-677
58. Kumar M.S., Pester R.E., Chen C.Y., Lane K., Chin C., Lu J., Kirsch D.G., Golub T.R., and Jacks T. Dicer1 functions as a haploinsufficient tumor suppressor. Genes Dev. 23 (2009) 2700-2704
59. Le M.T., Teh C., Shyh-Chang N., Xie H., Zhou B., Korzh V., Lodish H.F., and Lim B. MicroRNA-125b is a novel negative regulator of p53. Genes Dev. 23 (2009) 862-876
60. Lee R.C., Feinbaum R.L., and Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75 (1993) 843-854
61. Lee Y., Kim M., Han J., Yeom K.H., Lee S., Baek S.H., and Kim V.N. MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 23 (2004) 4051-4060
62. Lehmann U., Hasemeier B., Christgen M., Muller M., Romermann D., Langer F., and Kreipe H. Epigenetic inactivation of microRNA gene hsa-miR-9-1 in human breast cancer. J. Pathol. 214 (2008) 17-24
63. Lehrbach N.J., Armisen J., Lightfoot H.L., Murfitt K.J., Bugaut A., Balasubramanian S., and Miska E.A. LIN-28 and the poly(U) polymerase PUP-2 regulate let-7 microRNA processing in Caenorhabditis elegans. Nat. Struct. Mol. Biol. 16 (2009) 1016-1020
64. Leivonen S.K., Makela R., Ostling P., Kohonen P., Haapa-Paananen S., Kleivi K., Enerly E., Aakula A., Hellstrom K., Sahlberg N., Kristensen V.N., B ørresen-Dale A.L., Saviranta P., Perala M., and Kallioniemi O. Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines. Oncogene 28 (2009) 3926-3936
65. Li W., Duan R., Kooy F., Sherman S.L., Zhou W., and Jin P. Germline mutation of microRNA-125a is associated with breast cancer. J. Med. Genet. 46 (2009) 358-360
66. Li X.F., Yan P.J., and Shao Z.M. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer. Oncogene 28 (2009) 3937-3948
67. Liang Z., Wu H., Xia J., Li Y., Zhang Y., Huang K., Wagar N., Yoon Y., Cho H.T., Scala S., and Shim H. Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1. Biochem. Pharmacol. (2009)
68. Liu S., Goldstein R.H., Scepansky E.M., and Rosenblatt M. Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone. Cancer Res. 69 (2009) 8742-8751
69. Lodygin D., Tarasov V., Epanchintsev A., Berking C., Knyazeva T., Korner H., Knyazev P., Diebold J., and Hermeking H. Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell Cycle 7 (2008) 2591-2600
70. Lowery A.J., Miller N., Devaney A., McNeill R.E., Davoren P.A., Lemetre C., Benes V., Schmidt S., Blake J., Ball G., and Kerin M.J. MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer. Breast Cancer Res. 11 (2009) R27
71. Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., Sweet-Cordero A., Ebert B.L., Mak R.H., Ferrando A.A., Downing J.R., Jacks T., Horvitz H.R., and Golub T.R. MicroRNA expression profiles classify human cancers. Nature 435 (2005) 834-838
72. Lu Z., Liu M., Stribinskis V., Klinge C.M., Ramos K.S., Colburn N.H., and Li Y. MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene 27 (2008) 4373-4379
73. Luthra R., Singh R.R., Luthra M.G., Li Y.X., Hannah C., Romans A.M., Barkoh B.A., Chen S.S., Ensor J., Maru D.M., Broaddus R.R., Rashid A., and Albarracin C.T. MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers. Oncogene 27 (2008) 6667-6678
74. Ma L., Teruya-Feldstein J., and Weinberg R.A. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449 (2007) 682-688
75. Maillot G., Lacroix-Triki M., Pierredon S., Gratadou L., Schmidt S., Benes V., Roche H., Dalenc F., Auboeuf D., Millevoi S., and Vagner S. Widespread estrogen-dependent repression of microRNAs involved in breast tumor cell growth. Cancer Res. 69 (2009) 8332-8340
76. Mattie M.D., Benz C.C., Bowers J., Sensinger K., Wong L., Scott G.K., Fedele V., Ginzinger D., Getts R., and Haqq C. Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol. Cancer 5 (2006) 24
77. Mayr C., Hemann M.T., and Bartel D.P. Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 315 (2007) 1576-1579
78. Mertens-Talcott S.U., Chintharlapalli S., Li X., and Safe S. The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells. Cancer Res. 67 (2007) 11001-11011
79. Miller T.E., Ghoshal K., Ramaswamy B., Roy S., Datta J., Shapiro C.L., Jacob S., and Majumder S. MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1. J. Biol. Chem. 283 (2008) 29897-29903
80. Olive V., Bennett M.J., Walker J.C., Ma C., Jiang I., Cordon-Cardo C., Li Q.J., Lowe S.W., Hannon G.J., and He L. miR-19 is a key oncogenic component of miR-17-92. Genes Dev. 23 (2009) 2839-2849
81. Orom U.A., Nielsen F.C., and Lund A.H. MicroRNA-10a binds the 5'UTR of ribosomal protein mRNAs and enhances their translation. Mol. Cell 30 (2008) 460-471
82. Ota A., Tagawa H., Karnan S., Tsuzuki S., Karpas A., Kira S., Yoshida Y., and Seto M. Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res. 64 (2004) 3087-3095
83. Pan Y.Z., Morris M.E., and Yu A.M. MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells. Mol. Pharmacol. 75 (2009) 1374-1379
84. Park S., Gaur A., Lengyel E., and Peter M. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the e-cadherin repressors ZEB1 and ZEB2. Genes Dev. 22 (2008) 894-907
85. Perou C.M., Sorlie T., Eisen M.B., van de Rijn M., Jeffrey S.S., Rees C.A., Pollack J.R., Ross D.T., Johnsen H., Akslen L.A., Fluge O., Pergamenschikov A., Williams C., Zhu S.X., Lonning P.E., B ørresen-Dale A.L., Brown P.O., and Botstein D. Molecular portraits of human breast tumours. Nature 406 (2000) 747-752
86. Petersen C.P., Bordeleau M.E., Pelletier J., and Sharp P.A. Short RNAs repress translation after initiation in mammalian cells. Mol. Cell 21 (2006) 533-542
87. Pillai R.S., Bhattacharyya S.N., Artus C.G., Zoller T., Cougot N., Basyuk E., Bertrand E., and Filipowicz W. Inhibition of translational initiation by let-7 microRNA in human cells. Science 309 (2005) 1573-1576
88. Reddy S.D., Pakala S.B., Ohshiro K., Rayala S.K., and Kumar R. MicroRNA-661, a c/EBPalpha target, inhibits metastatic tumor antigen 1 and regulates its functions. Cancer Res. 69 (2009) 5639-5642
89. Reinhart B.J., Slack F.J., Basson M., Pasquinelli A.E., Bettinger J.C., Rougvie A.E., Horvitz H.R., and Ruvkun G. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403 (2000) 901-906
90. Rich A. The transfer of information between the nucleic acids. In: Rudnick D. (Ed). Synthesis of Molecular and Cellular Structure (1961), Ronald Press, New York 3-11
91. Saal L.H., Gruvberger-Saal S.K., Persson C., Lovgren K., Jumppanen M., Staaf J., Jonsson G., Pires M.M., Maurer M., Holm K., Koujak S., Subramaniyam S., Vallon-Christersson J., Olsson H., Su T., Memeo L., Ludwig T., Ethier S.P., Krogh M., Szabolcs M., Murty V.V., Isola J., Hibshoosh H., Parsons R., and Borg A. Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair. Nat. Genet. 40 (2008) 102-107
92. Sachdeva M., and Mo Y.Y. MicroRNA-145 suppresses cell invasion and metastasis by directly targeting Mucin 1. Cancer Res. (2009)
93. Saetrom P., Biesinger J., Li S.M., Smith D., Thomas L.F., Majzoub K., Rivas G.E., Alluin J., Rossi J.J., Krontiris T.G., Weitzel J., Daly M.B., Benson A.B., Kirkwood J.M., O'Dwyer P.J., Sutphen R., Stewart J.A., Johnson D., and Larson G.P. A risk variant in a miR-125b binding site in BMPR1B is associated with breast cancer pathogenesis. Cancer Res. 69 (2009) 7459-7465
94. Sandberg R., Neilson J.R., Sarma A., Sharp P.A., and Burge C.B. Proliferating cells express mRNAs with shortened 3' untranslated regions and fewer microRNA target sites. Science 320 (2008) 1643-1647
95. Sayed D., Rane S., Lypowy J., He M., Chen I.Y., Vashistha H., Yan L., Malhotra A., Vatner D., and Abdellatif M. MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths. Mol. Biol. Cell 19 (2008) 3272-3282
96. Scott G.K., Goga A., Bhaumik D., Berger C.E., Sullivan C.S., and Benz C.C. Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b. J. Biol. Chem. 282 (2007) 1479-1486
97. Sempere L.F., Christensen M., Silahtaroglu A., Bak M., Heath C.V., Schwartz G., Wells W., Kauppinen S., and Cole C.N. Altered microRNA expression confined to specific epithelial cell subpopulations in breast cancer. Cancer Res. 67 (2007) 11612-11620
98. Shen J., Ambrosone C.B., DiCioccio R.A., Odunsi K., Lele S.B., and Zhao H. A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis. Carcinogenesis 29 (2008) 1963-1966
99. Shimono Y., Zabala M., Cho R.W., Lobo N., Dalerba P., Qian D., Diehn M., Liu H., Panula S.P., Chiao E., Dirbas F.M., Somlo G., Pera R.A., Lao K., and Clarke M.F. Downregulation of miRna-200c links breast cancer stem cells with normal stem cells. Cell 138 (2009) 592-603
100. Si M.L., Zhu S., Wu H., Lu Z., Wu F., and Mo Y.Y. miR-21-mediated tumor growth. Oncogene 26 (2007) 2799-2803
101. Song F., Zheng H., Liu B., Wei S., Dai H., Zhang L., Calin G.A., Hao X., Wei Q., Zhang W., and Chen K. A miR-502-binding site single-nucleotide polymorphism in the 3'-untranslated region of the SET8 gene is associated with early age of breast cancer onset. Clin. Cancer Res. 15 (2009) 6292-6300
102. Suzuki H.I., Yamagata K., Sugimoto K., Iwamoto T., Kato S., and Miyazono K. Modulation of microRNA processing by p53. Nature 460 (2009) 529-533
103. Tan Y., Zhang B., Wu T., Skogerbo G., Zhu X., Guo X., He S., and Chen R. Transcriptional inhibiton of HoxD4 expression by miRNA-10a in human breast cancer cells. BMC Mol. Biol. 10 (2009) 12
104. Tatsuguchi M., Seok H.Y., Callis T.E., Thomson J.M., Chen J.F., Newman M., Rojas M., Hammond S.M., and Wang D.Z. Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. J. Mol. Cell Cardiol. 42 (2007) 1137-1141
105. Tavazoie S.F., Alarcon C., Oskarsson T., Padua D., Wang Q., Bos P.D., Gerald W.L., and Massague J. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451 (2008) 147-152
106. Tchatchou S., Jung A., Hemminki K., Sutter C., Wappenschmidt B., Bugert P., Weber B.H., Niederacher D., Arnold N., Varon-Mateeva R., Ditsch N., Meindl A., Schmutzler R.K., Bartram C.R., and Burwinkel B. A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal women. Carcinogenesis 30 (2009) 59-64
107. Thomson J.M., Newman M., Parker J.S., Morin-Kensicki E.M., Wright T., and Hammond S.M. Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev. 20 (2006) 2202-2207
108. Thum T., Gross C., Fiedler J., Fischer T., Kissler S., Bussen M., Galuppo P., Just S., Rottbauer W., Frantz S., Castoldi M., Soutschek J., Koteliansky V., Rosenwald A., Basson M.A., Licht J.D., Pena J.T., Rouhanifard S.H., Muckenthaler M.U., Tuschl T., Martin G.R., Bauersachs J., and Engelhardt S. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456 (2008) 980-984
109. Tryndyak V.P., Beland F.A., and Pogribny I.P. E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells. Int. J. Cancer (2009)
110. Tsuchiya Y., Nakajima M., Takagi S., Taniya T., and Yokoi T. MicroRNA regulates the expression of human cytochrome p450 1B1. Cancer Res. 66 (2006) 9090-9098
111. Valastyan S., Reinhardt F., Benaich N., Calogrias D., Szasz A.M., Wang Z.C., Brock J.E., Richardson A.L., and Weinberg R.A. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 137 (2009) 1032-1046
112. Valastyan S., Benaich N., Chang A., Reinhardt F., and Weinberg R.A. Concomitant suppression of three target genes can explain the impact of a microRNA on metastasis. Genes Dev. 23 (2009) 2592-2597
113. Varambally S., Cao Q., Mani R.S., Shankar S., Wang X., Ateeq B., Laxman B., Cao X., Jing X., Ramnarayanan K., Brenner J.C., Yu J., Kim J.H., Han B., Tan P., Kumar-Sinha C., Lonigro R.J., Palanisamy N., Maher C.A., and Chinnaiyan A.M. Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science 322 (2008) 1695-1699
114. Varnholt H., Drebber U., Schulze F., Wedemeyer I., Schirmacher P., Dienes H.P., and Odenthal M. MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma. Hepatology 47 (2008) 1223-1232
115. van Rooij E., Sutherland L.B., Liu N., Williams A.H., McAnally J., Gerard R.D., Richardson J.A., and Olson E.N. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc. Natl. Acad. Sci. USA 103 (2006) 18255-18260
116. van 't Veer L.J., Dai H., van de Vijver M.J., He Y.D., Hart A.A., Mao M., Peterse H.L., van der Kooy K., Marton M.J., Witteveen A.T., Schreiber G.J., Kerkhoven R.M., Roberts C., Linsley P.S., Bernards R., and Friend S.H. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415 (2002) 530-536
117. Ventura A., Young A.G., Winslow M.M., Lintault L., Meissner A., Erkeland S.J., Newman J., Bronson R.T., Crowley D., Stone J.R., Jaenisch R., Sharp P.A., and Jacks T. Targeted deletion reveals essential and overlapping functions of the miR-17∼92 family of miRNA clusters. Cell 132 (2008) 875-886
118. Viswanathan S.R., Powers J.T., Einhorn W., Hoshida Y., Ng T.L., Toffanin S., O'Sullivan M., Lu J., Phillips L.A., Lockhart V.L., Shah S.P., Tanwar P.S., Mermel C.H., Beroukhim R., Azam M., Teixeira J., Meyerson M., Hughes T.P., Llovet J.M., Radich J., Mullighan C.G., Golub T.R., Sorensen P.H., and Daley G.Q. Lin28 promotes transformation and is associated with advanced human malignancies. Nat. Genet. 41 (2009) 843-848
119. Volinia S., Calin G.A., Liu C.G., Ambs S., Cimmino A., Petrocca F., Visone R., Iorio M., Roldo C., Ferracin M., Prueitt R.L., Yanaihara N., Lanza G., Scarpa A., Vecchione A., Negrini M., Harris C.C., and Croce C.M. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. USA 103 (2006) 2257-2261
120. Wang S., Bian C., Yang Z., Bo Y., Li J., Zeng L., Zhou H., and Zhao R.C. miR-145 inhibits breast cancer cell growth through RTKN. Int. J. Oncol. 34 (2009) 1461-1466
121. Wang Y., Rathinam R., Walch A., and Alahari S.K. ST14 (suppression of tumorigenicity 14) gene is a target for miR-27b, and the inhibitory effect of ST14 on cell growth is independent of miR-27b regulation. J. Biol. Chem. 284 (2009) 23094-23106
122. Wang S., and Olson E.N. AngiomiRs-key regulators of angiogenesis. Curr. Opin. Genet. Dev. 19 (2009) 205-211
123. Webster R.J., Giles K.M., Price K.J., Zhang P.M., Mattick J.S., and Leedman P.J. Regulation of epidermal growth factor receptor signaling in human cancer cells by microRNA-7. J. Biol. Chem. 284 (2009) 5731-5741
124. Wickramasinghe N.S., Manavalan T.T., Dougherty S.M., Riggs K.A., Li Y., and Klinge C.M. Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in mcf-7 breast cancer cells. Nucleic Acids Res. 37 (2009) 2584-2595
125. Woltering J.M., and Durston A.J. miR-10 represses HoxB1a and HoxB3a in zebrafish. PLoS One 3 (2008) e1396
126. Wu F., Zhu S., Ding Y., Beck W.T., and Mo Y.Y. MicroRNA-mediated regulation of Ubc9 expression in cancer cells. Clin. Cancer Res. 15 (2009) 1550-1557
127. Wu H., Zhu S., and Mo Y.Y. Suppression of cell growth and invasion by miR-205 in breast cancer. Cell Res. 19 (2009) 439-448
128. Yan L.X., Huang X.F., Shao Q., Huang M.Y., Deng L., Wu Q.L., Zeng Y.X., and Shao J.Y. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 14 (2008) 2348-2360
129. Yang N., Kaur S., Volinia S., Greshock J., Lassus H., Hasegawa K., Liang S., Leminen A., Deng S., Smith L., Johnstone C.N., Chen X.M., Liu C.G., Huang Q., Katsaros D., Calin G.A., Weber B.L., Butzow R., Croce C.M., Coukos G., and Zhang L. MicroRNA microarray identifies let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer. Cancer Res. 68 (2008) 10307-10314
130. Yang R., Schlehe B., Hemminki K., Sutter C., Bugert P., Wappenschmidt B., Volkmann J., Varon R., Weber B.H., Niederacher D., Arnold N., Meindl A., Bartram C.R., Schmutzler R.K., and Burwinkel B. A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk. Breast Cancer Res. Treat. (2009)
131. Yu F., Yao H., Zhu P., Zhang X., Pan Q., Gong C., Huang Y., Hu X., Su F., Lieberman J., and Song E. Let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131 (2007) 1109-1123
132. Yu Z., Wang C., Wang M., Li Z., Casimiro M.C., Liu M., Wu K., Whittle J., Ju X., Hyslop T., McCue P., and Pestell R.G. A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation. J. Cell Biol. 182 (2008) 509-517
133. Zhang L., Huang J., Yang N., Greshock J., Megraw M.S., Giannakakis A., Liang S., Naylor T.L., Barchetti A., Ward M.R., Yao G., Medina A., O'brien-Jenkins A., Katsaros D., Hatzigeorgiou A., Gimotty P.A., Weber B.L., and Coukos G. MicroRNAs exhibit high frequency genomic alterations in human cancer. Proc. Natl. Acad. Sci. USA 103 (2006) 9136-9141
134. Zhang J., Du Y.Y., Lin Y.F., Chen Y.T., Yang L., Wang H.J., and Ma D. The cell growth suppressor, miR-126, targets IRS-1. Biochem. Biophys. Res. Commun. 377 (2008) 136-140
135. Zhang Y., Gao J.S., Tang X., Tucker L.D., Quesenberry P., Rigoutsos I., and Ramratnam B. MicroRNA 125a and its regulation of the p53 tumor suppressor gene. FEBS Lett. 583 (2009) 3725-3730
136. Zhao J.J., Lin J., Yang H., Kong W., He L., Ma X., Coppola D., and Cheng J.Q. MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer. J. Biol. Chem. 283 (2008) 31079-31086
137. Zhu S., Si M.L., Wu H., and Mo Y.Y. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J. Biol. Chem. 282 (2007) 14328-14336
138. Zhu S., Wu H., Wu F., Nie D., Sheng S., and Mo Y.Y. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res. 18 (2008) 350-359